Natus Medical Incorporated (NTUS)
| Market Cap | 1.13B |
| Revenue (ttm) | 478.30M |
| Net Income (ttm) | 12.68M |
| Shares Out | 34.59M |
| EPS (ttm) | 0.38 |
| PE Ratio | 87.44 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 134,799 |
| Open | 32.72 |
| Previous Close | 32.78 |
| Day's Range | 32.68 - 32.85 |
| 52-Week Range | 20.90 - 33.93 |
| Beta | 0.23 |
| Analysts | Sell |
| Price Target | n/a |
| Earnings Date | May 5, 2022 |
About NTUS
Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, an...
Financial Performance
Financial StatementsNews
The M&A Class Action Firm Continues the Investigation of Natus Medical Inc. - NTUS
New York, New York--(Newsfile Corp. - May 24, 2022) - Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securiti...
NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequac...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Natus Medical Inco...
NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequac...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Natus Medical Inco...
Natus Medical Announces First Quarter 2022 Financial Results
MIDDLETON, Wis., May 05, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disor...
Has Natus Medical (NTUS) Outpaced Other Medical Stocks This Year?
Here is how Natus Medical (NTUS) and Option Care (OPCH) have performed compared to their sector so far this year.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ACC, NTUS, FSI, VWTR
NEW YORK , April 26, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Natus Medical Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - April 19, 2022) - Rigrodsky Law, P.A. is investigating Natus Medical Inc. ("Natus") (NASDAQ: NTUS) regarding possible breaches of fiduciary duties and other viola...
Here is why Natus Medical is up 25%
Natus Medical Incorporated (NASDAQ: NTUS) shares are up 25% after the medical device solutions provider for screening, diagnosing and treating disorders that affect the brain sensory nervous systems ad ...
Why Natus Medical Stock Surged Today
A suitor wants to take the company private.
SHAREHOLDER ALERT: Weiss Law Investigates Natus Medical Incorporated
NEW YORK, April 18, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Natus Medical Incorporated ("Natus" or th...
Shareholder Alert: Wisconsin firm Ademi LLP investigates whether Natus Medical Incorporated has obtained a Fair Price...
MILWAUKEE , April 18, 2022 /PRNewswire/ -- Ademi LLP is investigating Natus (NASDAQ:NTUS) for possible breaches of fiduciary duty and other violations of law in its transaction with ArchiMed. Click her...
NTUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Natus Medical Incorporated Is Fair to Shareho...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Natus Medical Incorporated (NASDAQ: NTUS) to an affiliate of ArchiMed for $33.50 in cash pe...
Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal
Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion. Natus shareholders will receive $33.50 ...
Natus Medical to be acquired at a 29% premium by ArchiMed
Natus Medical Inc. NTUS, +0.58% announced Monday a deal to be acquired in a deal valued at $1.2 billion by an affiliate of investment firm ArchiMed. Natus Medical's stock was still halted for news until...
Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash
Highlights:
Natus Medical to Hold 2022 First Quarter Financial Results Conference Call on May 6th
PLEASANTON, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and ...
Is Natus Medical (NTUS) a Worthy Stock for Value Investors?
Is Natus Medical (NATUS) a great pick from the value investor's perspective right now? Read on to know more.
All You Need to Know About Natus Medical (NTUS) Rating Upgrade to Buy
Natus Medical (NTUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Natus Medical (NTUS) Beats Q4 Earnings and Revenue Estimates
Natus Medical (NTUS) delivered earnings and revenue surprises of 6.82% and 0.51%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Natus Medical Announces Fourth Quarter 2021 Financial Results
PLEASANTON, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat d...
Natus Medical (NTUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
PLEASANTON, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and tre...
Natus to Participate in the 24th Annual Needham Virtual Growth Conference
PLEASANTON, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...
Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February 25th
PLEASANTON, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and t...
Natus Medical Announces Executive Transition
Thomas J. Sullivan Appointed President & Chief Executive Officer